Announcements Trials
Browse Landscape

Phase

Phase NA 22Phase 2 4Phase 4 3Phase 3 3Phase 2/3 2Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 3

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Inositol × Clear all
NCT03059173 2026-04-22

MYOPK

University Hospital, Lille

Phase 3 Recruiting
276 enrolled

Polycystic Ovary Syndrome

NCT07323589 2026-01-07

Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS

PAEC general hospital

Phase 3 Completed
120 enrolled

Polycystic Ovary Syndrome

NCT06405243 2024-05-08

Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

Beni-Suef University

Phase 3 Not yet recruiting
100 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡